On Monday, representatives from the IPD spoke on a panel at Xconomy’s EXOME’s Seattle’s Life Science Disruptors 2016 event. It was titled “Proteins Like You’ve Never Seen” and included Lucas Nivon (Cyrus), Ingrid Swanson Putlz (PvP Biologics), Aaron Chevalier (Virvio), and David Baker. The event’s description was as follows:
Seattle is one of the few cities in the world with a dense confluence of biotechnology, medicine, information technology, and public health expertise, and a footprint small enough to encourage intense collaboration between the sectors. From that mix come new ideas, products, and organizations that aim to change the way new therapies are created are created and how people in the U.S. and around the world get their healthcare.
On May 2, we’ll gather at the Fred Hutchinson Cancer Research Center to hear from and talk to some of the most forward-thinking scientists, executives, entrepreneurs, and investors from Seattle and beyond whose work is shaking up entrenched healthcare practices. New drugs. Global initiatives. Better prevention and diagnosis. Deeper analysis. Join us for a healthy dose of thought-provoking conversation.
